Zephyr Sleep Technologies has secured several patents with the United States Patent and Trademark Office (USPTO). The MATRx plus is the only home sleep test with an auto-titrating mandibular position and it received De Novo approval by the FDA in 2018.
Covered by one or more of the following US patents: 8,783,260; 10,195,070; 10,709,598; or international equivalents. Other patents pending.
Covered by one or more of the following US patents: 8,783,260; 10,172,548; 10,492,722; 10,709,598; 10,709,599; or international equivalents. Other patents pending.
Covered by one or more of the following US patents: 8,783,260; 10,709,598; or international equivalents.
To read some of the dental sleep medicine research and the clinical validation of Zephyr’s products, please take a look at the abstracts.
Dental Sleep Medicine Research